Ledger.Open graph →
SEC Form D · Amendment · filed May 28, 2020

Nautilus Biotechnology, Inc

Offering
$76.1M
Sold
$76.1M
Exemption
Rule 506(b)
Industry
Other
Location
San Carlos, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Matthew Posard · San Carlos, CADirectorStuart Nagae · San Carlos, CADirectorFarzad Nazem · San Carlos, CADirectorSujal Patel · San Carlos, CAExec · DirectorVijay Pande · San Carlos, CADirectorParag Mallick · San Carlos, CADirectorJay C. Hoag · Menlo Park, CADirectorMatt Mulherin · Rogers, ARDirectorTrinda Blackmore · Grand Cayman, Cayman IslandsDirectorMeagan Bowman · Rogers, ARExec · DirectorKhang Ting · HONG KONG, Hong KongDirectorTerry Knoploh · Rogers, ARDirectorRichard Jacinto Ii · RICHMOND, British Columbia, CanadaDirectorTodd Asmuth · New York, NYExec · DirectorAshley Thompson · Chicago, ILDirectorSam Mcbride · Chicago, ILDirectorGuillermo Freile · Chicago, ILDirectorMatthew A. Mccall · Conway, SCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗